Drug Database
Back to search

Poland· PL-100284690

Desloratadine Genepharm

A desloratadine product containing desloratadinum, registered in Poland by Genepharm S.A.. The same ATC class is registered in 19 of our 19 countries.

ATC R06AX27

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedDesloratadine GenepharmATCR06AX27REGISTER NO.PL-100284690PACKS LISTED12CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about desloratadinumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Desloratadine is registered in 19 of 19 countries.

Countries holding a registration under ATC R06AX27 (desloratadine), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 11 of them publish a price we can compare per daily dose
Search desloratadine products by name

Desloratadine · ATC R06AX27

19 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of desloratadine costs, country by country.

Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.13 in France to $0.51 in Switzerland — a ×3.8 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Desloratadine · price per daily dose (5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.51
  • IT Italy$0.23
  • FR France$0.13
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Desloratadinum
Manufacturer
Genepharm S.A.
Country
Poland (PL)
ATC code
R06AX27
ATC class
Desloratadine
Defined daily dose
5 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 12

  • gtin
    05909991002176
  • gtin
    05909991002183
  • gtin
    05909991002190
  • gtin
    05909991002206
  • gtin
    05909991002220
  • gtin
    05909991002237
  • gtin
    05909991002244
  • gtin
    05909991002251
  • gtin
    05909991002268
  • gtin
    05909991002275
  • gtin
    05909991002282
  • gtin
    05909991002299

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

322 interactions on record for desloratadine.

Graded by severity as the source publishes them — 4 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check desloratadine against other medicinesHow interaction checks work

Desloratadine · interactions on record

322 records

  • 4 moderate
  • 4 minor
  • 314 info

Most severe, free to view

  • Histamine dihydrochlorideL03AX14moderate
  • PitolisantN07XX11moderate
  • TuberculinV04CF01moderate
  • Histamine phosphateV04CG03moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Desloratadine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All desloratadine products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Desloraderm, Desloratadin +pharma
  • Belgium · Desloratadin Sandoz, Desloratadine Ab
  • Bulgaria · Дасергин, Десалерган
  • Cyprus · Dareq
  • Czechia · Daslodil, Dasmini
  • Germany · Deslopuren, Deslora
  • Denmark · Desloratadin "glenmark", Desloratadin Gea
  • Estonia · Dasergin, Desloratadine Sopharma
  • Spain · Dasergin, Desloratadina Almus
  • Finland · Caredin, Dasergin
  • France · Desloratadine Almus, Desloratadine Arrow
  • United Kingdom (Northern Ireland) · Desloratadine, Desloratadine Accord Healthcare
  • Greece · Desloratadine Genepharm, Desloratadine Target
  • Croatia · Aerogal, Alerdin
  • Hungary · Dassergo, Desloratadin Teva
  • Ireland · Deslor, Desloratadine Glenmark
  • Iceland · Aerius, Azomyr
  • Italy · Aremas, Desloratadina Aurobindo Italia
  • Liechtenstein · Aerius, Azomyr
  • Lithuania · Dassniz, Desloratadine Sopharma
  • Luxembourg · Desloratadine Eg, Desloratadine Eurogenerics
  • Latvia · Dassniz, Desloratadine Sopharma
  • Malta · Dareq, Deslor
  • Netherlands · Desloratadine Accord, Desloratadine Aurobindo
  • Norway · Aerius, Azomyr
  • Portugal · Bluesar, Clarus
  • Romania · Dasergin, Desloratadina Fiterman
  • Sweden · Caredin, Desloratadin Abece
  • Slovenia · Dasselta Control, Lentrica
  • Slovakia · Daslodil, Dasseltino

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b254ec9e-b76b-44a4-8a41-b625ab86c55b
GET /v1/drugs/b254ec9e-b76b-44a4-8a41-b625ab86c55b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki ulegające rozpadowi w jamie ustnej",
  "source": "urpl",
  "strength": "2,5 mg",
  "packaging": "05909991002176 ¦ Rp ¦ 78763\n5 tabl.\n05909991002183 ¦ Rp ¦ 78764\n6 tabl.\n05909991002190 ¦ Rp ¦ 78765\n10 tabl.\n05909991002206 ¦ Rp ¦ 78766\n12 tabl.\n05909991002220 ¦ Rp ¦ 78767\n15 tabl.\n05909991002237 ¦ Rp ¦ 78768\n18 tabl.\n05909991002244 ¦ Rp ¦ 78769\n20 tabl.\n05909991002251 ¦ Rp ¦ 78770\n30 tabl.\n05909991002268 ¦ Rp ¦ 78771\n50 tabl.\n05909991002275 ¦ Rp ¦ 78772\n60 tabl.\n05909991002282 ¦ Rp ¦ 78773\n90 tabl.\n05909991002299 ¦ Rp ¦ 78774\n100 tabl.",
  "substance": "Desloratadinum 2.5 mg",
  "common_name": "Desloratadinum",
  "pl_product_id": "100284690",
  "pozwolenie_nr": "20491",
  "auth_procedure": "DCP",
  "authorisation_validity": "2023-11-13"
}
API referenceMCP serverPlans

See everything about desloratadine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console